Literature DB >> 1986951

The window of embryo transfer and the efficiency of human conception in vitro.

D Navot1, R T Scott, K Droesch, L L Veeck, H C Liu, Z Rosenwaks.   

Abstract

Women with ovarian failure transferred with donated oocytes provide a unique in vivo model for the elucidation of the window of implantation and efficiency of reproduction in the human. Throughout 52 ovum donation cycles, the temporal window of endometrial receptivity was tested by replacing 2- to 12-cell embryos between days 16 and 24 of hormonally and histologically defined cycles. Of 37 transfers within days 17 to 19, 15 (40.5%) conceptions occurred. Twelve (32.4%) have reached viability. Of 11 patients transferred on days greater than or equal to 20, none conceived. Likewise, no pregnancies were achieved with 4 transfers on cycle day 16. Analysis of multiple embryo transfers within the suggested window of endometrial receptivity (days 17 to 19) revealed 14 of 24 (58.3%) to be conception cycles. considering only transfers with two or more embryos, at least one of which is of high quality (grades 1 to 2), yielded a 63.2% pregnancy rate. The results indicate a very high efficiency for in vitro fecundity provided optimal conditions are attained. The concepts leading to success in the ovum donation model should set the course for continued research toward improving results in other forms of assisted reproduction.

Entities:  

Mesh:

Year:  1991        PMID: 1986951     DOI: 10.1016/s0015-0282(16)54069-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  40 in total

1.  The endometrium and embryo implantation. A receptive endometrium depends on more than hormonal influences.

Authors:  A W Horne; J O White; E N Lalani
Journal:  BMJ       Date:  2000-11-25

2.  Ovum donation: ethical and legal aspects.

Authors:  J G Schenker
Journal:  J Assist Reprod Genet       Date:  1992-10       Impact factor: 3.412

3.  Human cleavage-stage embryo vitrification is comparable to slow-rate cryopreservation in cycles of assisted reproduction.

Authors:  Martin Graham Wilding; Clemente Capobianco; Nadia Montanaro; Genc Kabili; Loredana Di Matteo; Enrico Fusco; Brian Dale
Journal:  J Assist Reprod Genet       Date:  2010-07-17       Impact factor: 3.412

Review 4.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

5.  Impact of serum estradiol levels on the implantation rate of cleavage stage cryopreserved-thawed embryos transferred in programmed cycles with exogenous hormonal replacement.

Authors:  Silvina Bocca; Elvira Bondía Real; Susanna Lynch; Laurel Stadtmauer; Hind Beydoun; Jacob Mayer; Sergio Oehninger
Journal:  J Assist Reprod Genet       Date:  2015-01-07       Impact factor: 3.412

Review 6.  What is the contribution of embryo-endometrial asynchrony to implantation failure?

Authors:  Wan-Tinn Teh; John McBain; Peter Rogers
Journal:  J Assist Reprod Genet       Date:  2016-08-01       Impact factor: 3.412

Review 7.  Adverse effect of prematurely elevated progesterone in in vitro fertilization cycles: a literature review.

Authors:  Michael B Evans; Mae W Healy; Alan H DeCherney; Micah J Hill
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

8.  The optimum time for exogenous human chorionic gonadotropin to rescue the corpus luteum.

Authors:  P Y Tay; E A Lenton
Journal:  J Assist Reprod Genet       Date:  1999-10       Impact factor: 3.412

9.  Regulation of human endometrial stromal proliferation and differentiation by C/EBPβ involves cyclin E-cdk2 and STAT3.

Authors:  Wei Wang; Robert N Taylor; Indrani C Bagchi; Milan K Bagchi
Journal:  Mol Endocrinol       Date:  2012-10-24

Review 10.  Ovum donation--an overview.

Authors:  A Benshushan; J G Schenker
Journal:  J Assist Reprod Genet       Date:  1993-02       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.